Quantinuum's IPO plans come ​at ⁠a time when companies are exploring ways to develop and scale quantum capabilities to solve ...

Investors are eyeing a rebound in the ‌U.S. ​biotech sector in 2026, as more companies are ‌expected to go public amid a renewed deal-making appetite and a lower interest rate scenario, even as they ...

Authum Investment & Infrastructure board had recommended an issue of bonus shares in the ratio of 4:1, while Best Agrolife ...